New clinical trial for adolescents and adults with Fragile X Syndrome 14-50 years of age

PURPOSE: to study the effectiveness and safety of a new drug that is being developed to improve the symptoms of

Fragile X Syndrome

Sponsored by Pharmaceuticals

Taking place at The Kennedy Krieger Institute, Baltimore, Maryland

PI: Michael V. Johnston, MDKennedy Krieger Institute

Co-I: Dejan Budimirovic, MDDirector, Fragile X Clinic

Kennedy Krieger Institute

Co-I: Tanjala Gipson, MDKennedy Krieger Institute

This research study is free. You will be given $50 for reimbursement for travel and related expenses for each

completed visit. Call 443-923-7619 for more information.Protocol Number: NA_00049393

Approved May 8, 2013